Clinical trial
Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in…
NCT00268684 · Tel-Aviv Sourasky Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00268684 |
|---|---|
| Title | Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC |
| Official title | A Phase III Trial Comparing Whole Brain Radiation (WBRT) and Stereotactic Radiosurgery (SRS) Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases |
| Lead sponsor | Tel-Aviv Sourasky Medical Center, Other |
| Collaborators | Radiation Therapy Oncology Group |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | Erlotinib, Temozolomide |
| Enrollment | 381 |
| Start date | May 1, 2005 |
| First posted | Dec 22, 2005 |
| Last update posted | Feb 28, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: